Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03535350
Title Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications

glioblastoma

Therapies

Ibrutinib

Ibrutinib + Temozolomide

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland Ohio 44195 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field